APRIL TOWLER: Open Payments
NPI 1851547855 · WILLIAMSBURG, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$309 in 15 payments from 7 companies in 2025. Trend: 2023 $126 · 2024 $273 · 2025 $309
Food & beverage: $309
| Company | Payments | Amount |
|---|---|---|
| SCPHARMACEUTICALS INC. | 7 | $156 |
| Amgen Inc. | 3 | $61 |
| Novartis Pharmaceuticals Corporation | 1 | $23 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $18 |
| AstraZeneca Pharmaceuticals LP | 1 | $17 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 1 | $17 |
| Abbott Laboratories | 1 | $17 |
Products named: FUROSCIX, REPATHA, LEQVIO, Kerendia, FARXIGA, LifeVest, JOT DX.
Industry payments across VA — which companies pay providers there.
